<html>
<head>PUBMED IDs for I-BABP</head>
<body bgcolor='#C5F0F2'><h1>I-BABP</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8612808/'>Effect of bile on the intestinal bile-acid binding protein (I-BABP) expression. In vitro and in vivo studies.</a> April 15  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/10514450/'>Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer.</a> October 9  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11254888/'>The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.</a> March 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11684682/'>Sterol regulatory element-binding protein-1c is responsible for cholesterol regulation of ileal bile acid-binding protein gene in vivo. Possible involvement of liver-X-receptor.</a> October 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12479580/'>Regulation of the ileal bile acid-binding protein gene: an approach to determine its physiological function(s).</a> December 14  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12525500/'>Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.</a> January 15  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14572640/'>FXRE can function as an LXRE in the promoter of human ileal bile acid-binding protein (I-BABP) gene.</a> October 24  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14770367/'>[Is the ileal bile acid-binding protein (I-BABP) gene involved in cholesterol homeostasis?].</a> February 11  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15936983/'>The gene encoding the human ileal bile acid-binding protein (I-BABP) is regulated by peroxisome proliferator-activated receptors.</a> June 7  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16230354/'>Ileal bile acid-binding protein, functionally associated with the farnesoid X receptor or the ileal bile acid transporter, regulates bile acid activity in the small intestine.</a> October 19  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16522742/'>1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.</a> March 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16706681/'>FXR: a target for cholestatic syndromes?</a> May 19  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19864602/'>The bile acid receptor FXR is a modulator of intestinal innate immunity.</a> December 16  2009<br></body></html>
